The decision by Health and Human Services (HHS) to end nearly $500 million in grants and contracts for developing mRNA vaccines has stirred concerns from BIO and others. What’s impacted: 22 projects ...

Prior to the case study exercise, Silas Buchanan Founding CEO of the Institute for eHealth Equity will provide a framework to use for underserved-community outreach and how to avoid failure points. He ...

The end of a busy week brings a new draft BIOSECURE Act—which takes into consideration BIO’s survey findings—and a plan to coordinate and streamline federal regulation of plants, animals, and ...

House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement: "The BIOSECURE bill released in the House today ...

The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation ...

In a win for patients, the Virginia Governor vetoed legislation establishing a Prescription Drug Affordability Board (PDAB). Meanwhile, yesterday’s hearing on ERISA highlighted AFP and PBM abuses.

We have a quick video recap of yesterday’s White House listening session on PBMs, plus optimism about biotech IPOs and biotech fashion. (678 words, 3 minutes, 23 seconds) ...

Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not ...

We recap a busy week, with activity on drug price controls and a look at alarming surges in measles around the world. (484 words, 2 minutes, 25 seconds) Drug price controls are coming – here’s what’s ...

COVID-19, flu, and RSV are here—but for the first winter ever, we have vaccines for all three. Meanwhile, USDA has awarded $19 million in grants to boost biofuels. (417 words, 2 minutes, 5 seconds) ...

BIO recently submitted comments to the U.S. Senate on the 340B program—here’s what we said, plus a recap of a successful BIO Asia-Taiwan. (406 words, 2 minutes, 1 second) 340B needs reform, BIO tells ...

The Senate HELP Committee today released a discussion draft of legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). BIO represents many small- and mid-size companies that ...